The Importance of Addressing Multiple Risk Markers in Type 2 Diabetes: Results from the leader trial
This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference by Dr Emilie Hein from